The iTAP Study for Veterans (iTAP-V)
Primary Purpose
Insomnia, Alcohol; Harmful Use
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cognitive Behavioral Therapy for Insomnia
Sleep Hygeine
Sponsored by
About this trial
This is an interventional treatment trial for Insomnia focused on measuring alcohol, drinking, sleep, insomnia, veteran
Eligibility Criteria
Inclusion criteria:
- Veteran deployed for military service after September 11, 2001
- 1+ heavy drinking episode (4/5+ drinks in 2 hours for women/men) in past 30 days
- DSM-5 and research diagnostic criteria for Insomnia Disorder
Exclusion Criteria:
- Inability to provide informed consent
- Cognitive impairment
- Contraindications for CBT-I (mania or seizure disorder)
- Untreated sleep disorder requiring more than behavioral treatment for insomnia
- Engagement in overnight shift work at baseline
- Care of a child under 1 year of age
- Severe or untreated psychiatric disorder that requires immediate clinical attention
- Current behavioral treatment for insomnia or alcohol use
- Initiation of sleep medication in the past 6 weeks
Sites / Locations
- University of Missouri-ColumbiaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
CBT-I
Sleep Hygiene
Arm Description
Individual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for six (6) weeks.
Sleep hygiene handout delivered once to all participants.
Outcomes
Primary Outcome Measures
Recruitment
Number of participants who complete baseline assessment
Retention
Number of participants who complete all treatment sessions
Drinking quantity
Assessed using Timeline Followback and Daily Drinking Questionnaire
Alcohol-related consequences
Assessed using the Brief Young Adult Alcohol Consequences Questionnaire
Insomnia symptoms
Assessed using Insomnia Severity Index (ISI); ISI evaluates self-reports of insomnia experiences
Sleep quality
Assessed using daily sleep diaries
Sleep efficiency
Assessed using daily sleep diaries and actigraphy
Client satisfaction
Assessed using the Client Satisfaction Questionnaire
Secondary Outcome Measures
Working memory updating
Assessed using the Keep Track task as described by Friedman et al (2008).
Working memory updating
Assessed using the N-Back Task as described in Jaeggi et al (2010).
Working memory updating
Assessed using the Letter Memory task as described in Miyake & Friedman (2012)
Response inhibition
Assessed using the Stop Signal task
Self-reported executive function
Assessed using the Behavior Rating Inventory of Executive Function of Adults
Delay discounting
Assessed using the Monetary Choice Questionnaire (MCQ). Participants indicate if they would rather receive a smaller amount of money now or a greater amount of money in a specified amount of time (e.g., 100 days, 2 days). The MCQ is scored using a logarithmic subject-specific discount rate (k variable; see Kirby, Petry, & Bickel, 1999). Higher k values indicate a greater preference for smaller, immediate rewards over larger, delayed reward.
Delay discounting
Assessed using the 5-trial delay discounting task
Negative affect
Assessed using the Positive and Negative Affect Schedule. Participants indicate using a 1 (not at all) - 5 (extremely) scale to indicate to what extent they feel negative emotions. The final score is the sum of the ten negative emotions/feelings. Higher scores indicate more negative affect.
Emotion regulation
Assessed using the Difficulties in Emotion Regulation Scale (DERS-16). The DERS-16 is a shortened version of the DERS scale. It measures emotion dysregulation based on subscales of clarity, goals, strategies, impulses, and non-acceptance.
Alcohol craving
Assessed using the Penn Alcohol Craving Scale (PACS); PACS evaluates thoughts about drinking by assessing the duration, frequency, and intensity of such thoughts.
Use of alcohol to help with sleep
Assessed using daily sleep diaries
Use of sleep medication
Assessed using daily sleep diaries
Autonomic arousal
Assessed using holter monitoring devices that provide a physiological index of arousal in the autonomic nervous system.
Full Information
NCT ID
NCT03804788
First Posted
January 9, 2019
Last Updated
June 20, 2023
Sponsor
University of Missouri-Columbia
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
1. Study Identification
Unique Protocol Identification Number
NCT03804788
Brief Title
The iTAP Study for Veterans
Acronym
iTAP-V
Official Title
The Impact of Insomnia Treatment on Heavy Alcohol Use Among Returning Veterans
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 4, 2019 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
September 30, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Missouri-Columbia
Collaborators
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This project aims to evaluate improvement of insomnia as a mechanism of improvement in alcohol use outcomes.
Detailed Description
More than half of returning Veterans who screen positive for hazardous drinking report clinically significant symptoms of insomnia. In turn, insomnia symptoms have been associated with increased risk of alcohol-related problems, perhaps due to insomnia-related impairments in executive functioning, negative emotionality, and craving. The proposed project aims to examine improvements in insomnia as a mechanism for improvement in alcohol use among heavy-drinking Veterans with insomnia. Forty-four returning Veterans who report heavy drinking (≥4/5 drinks per occasion for women/men) and have insomnia based on DSM-5 and research diagnostic criteria will participate in a randomized pilot trial. Participants will be randomly assigned to receive personalized normative alcohol feedback in the context of one of two treatment conditions: CBT-I (n = 22) or a sleep hygiene education control (SH; n = 22). Outcomes will be assessed at the end of the active intervention period (6 weeks), mid-treatment (after 3 sessions), and at 3 months post-intervention. Outcomes of interest include insomnia severity, total wake time, sleep quality, drinking quantity/frequency, alcohol-related consequences, executive functioning, negative affect, emotion regulation, craving for alcohol, and use of alcohol as a sleep aid.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia, Alcohol; Harmful Use
Keywords
alcohol, drinking, sleep, insomnia, veteran
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Subjects will be randomized to receive sleep hygiene or to participate in sessions of individual Cognitive Behavioral Therapy for Insomnia (CBT-I).
Masking
ParticipantOutcomes Assessor
Masking Description
PI Miller will be blind to participant assignment because the project manager will inform study therapists of participant assignment to conditions. PI Miller and study therapists will be blinded to assessment outcomes, and assessment RAs will be blinded to participant condition. All participants will be told that they are receiving treatment for insomnia in order to blind them to condition assignment (sleep hygiene will be described as "brief" insomnia treatment, and CBT-I will be described as the "most intense" treatment).
Allocation
Randomized
Enrollment
68 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
CBT-I
Arm Type
Experimental
Arm Description
Individual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for six (6) weeks.
Arm Title
Sleep Hygiene
Arm Type
Active Comparator
Arm Description
Sleep hygiene handout delivered once to all participants.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Behavioral Therapy for Insomnia
Other Intervention Name(s)
(CBT-I)
Intervention Description
Cognitive Behavioral Therapy for Insomnia (CBT-I). Participants assigned to the CBT-I condition will attend 1-hour individual sessions of CBT-I once a week for five weeks. A sixth week of treatment will be included - and scheduled for the same date as the post-treatment assessment - if the participant and research team agree that it would be beneficial (e.g., if a participant has difficulty grasping cognitive therapy concepts). Consistent with clinical guidelines (Schutte-Rodin, Broch, Buysse, Dorsey, & Sateia, 2008), treatment will include stimulus control (e.g., limit use of bed to sleep or sexual activity, get out of bed if lying awake for more than 20 minutes), sleep restriction (limit time in bed to amount of time spent sleeping on a typical night), sleep hygiene (e.g., avoid exercise within 2 hours of bedtime, create cool and dark sleep environment), relaxation training, and cognitive restructuring.
Intervention Type
Behavioral
Intervention Name(s)
Sleep Hygeine
Intervention Description
All participants will receive a one-page handout on sleep hygiene that includes personalized normative feedback on their alcohol use. This is the only intervention that participants assigned to the Sleep Hygiene condition will receive and is consistent with what may be expected as standard care in a doctor's visit with a primary care physician.
Primary Outcome Measure Information:
Title
Recruitment
Description
Number of participants who complete baseline assessment
Time Frame
Assessed at post-treatment (weeks 7-8)
Title
Retention
Description
Number of participants who complete all treatment sessions
Time Frame
Assessed at post-treatment (weeks 7-8)
Title
Drinking quantity
Description
Assessed using Timeline Followback and Daily Drinking Questionnaire
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Alcohol-related consequences
Description
Assessed using the Brief Young Adult Alcohol Consequences Questionnaire
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Insomnia symptoms
Description
Assessed using Insomnia Severity Index (ISI); ISI evaluates self-reports of insomnia experiences
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Sleep quality
Description
Assessed using daily sleep diaries
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Sleep efficiency
Description
Assessed using daily sleep diaries and actigraphy
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Client satisfaction
Description
Assessed using the Client Satisfaction Questionnaire
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Secondary Outcome Measure Information:
Title
Working memory updating
Description
Assessed using the Keep Track task as described by Friedman et al (2008).
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Working memory updating
Description
Assessed using the N-Back Task as described in Jaeggi et al (2010).
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Working memory updating
Description
Assessed using the Letter Memory task as described in Miyake & Friedman (2012)
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Response inhibition
Description
Assessed using the Stop Signal task
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Self-reported executive function
Description
Assessed using the Behavior Rating Inventory of Executive Function of Adults
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Delay discounting
Description
Assessed using the Monetary Choice Questionnaire (MCQ). Participants indicate if they would rather receive a smaller amount of money now or a greater amount of money in a specified amount of time (e.g., 100 days, 2 days). The MCQ is scored using a logarithmic subject-specific discount rate (k variable; see Kirby, Petry, & Bickel, 1999). Higher k values indicate a greater preference for smaller, immediate rewards over larger, delayed reward.
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Delay discounting
Description
Assessed using the 5-trial delay discounting task
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Negative affect
Description
Assessed using the Positive and Negative Affect Schedule. Participants indicate using a 1 (not at all) - 5 (extremely) scale to indicate to what extent they feel negative emotions. The final score is the sum of the ten negative emotions/feelings. Higher scores indicate more negative affect.
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Emotion regulation
Description
Assessed using the Difficulties in Emotion Regulation Scale (DERS-16). The DERS-16 is a shortened version of the DERS scale. It measures emotion dysregulation based on subscales of clarity, goals, strategies, impulses, and non-acceptance.
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Alcohol craving
Description
Assessed using the Penn Alcohol Craving Scale (PACS); PACS evaluates thoughts about drinking by assessing the duration, frequency, and intensity of such thoughts.
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Use of alcohol to help with sleep
Description
Assessed using daily sleep diaries
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Use of sleep medication
Description
Assessed using daily sleep diaries
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
Title
Autonomic arousal
Description
Assessed using holter monitoring devices that provide a physiological index of arousal in the autonomic nervous system.
Time Frame
Change from baseline to post-treatment (weeks 7-8) and 3 month follow-up (weeks 21-22)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria:
Veteran deployed for military service after September 11, 2001
1+ heavy drinking episode (4/5+ drinks in 2 hours for women/men) in past 30 days
DSM-5 and research diagnostic criteria for Insomnia Disorder
Exclusion Criteria:
Inability to provide informed consent
Cognitive impairment
Contraindications for CBT-I (mania or seizure disorder)
Untreated sleep disorder requiring more than behavioral treatment for insomnia
Engagement in overnight shift work at baseline
Care of a child under 1 year of age
Severe or untreated psychiatric disorder that requires immediate clinical attention
Current behavioral treatment for insomnia or alcohol use
Initiation of sleep medication in the past 6 weeks
Facility Information:
Facility Name
University of Missouri-Columbia
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65212
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary Beth Miller, PhD
Phone
573-882-1813
Email
millmary@health.missouri.edu
First Name & Middle Initial & Last Name & Degree
Nicole Hall, BA
Phone
573-882-8598
Email
nahcdv@health.missouri.edu
12. IPD Sharing Statement
Learn more about this trial
The iTAP Study for Veterans
We'll reach out to this number within 24 hrs